Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine with ropivacaine scalp nerve block for post-craniotomy analgesia
ChiCTR1900021429Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Mar 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine and ropivacaine in postoperative pain (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Total analgesic drug consumption within 24 hours after surgery and Time to first postoperative analgesic use. Planned start Mar 2019; status: not yet recruiting.
02
Drugs
dexmedetomidineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR1900021429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021429.